Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Apr 7;18(4):785.
doi: 10.3390/ijms18040785.

Translocator Protein-18 kDa (TSPO) Positron Emission Tomography (PET) Imaging and Its Clinical Impact in Neurodegenerative Diseases

Anne-Claire Dupont  1   2 , Bérenger Largeau  3 , Maria Joao Santiago Ribeiro  4   5 , Denis Guilloteau  6   7 , Claire Tronel  8 , Nicolas Arlicot  9   10
Affiliations
Review

Translocator Protein-18 kDa (TSPO) Positron Emission Tomography (PET) Imaging and Its Clinical Impact in Neurodegenerative Diseases

Anne-Claire Dupont et al. Int J Mol Sci. .

Abstract

In vivo exploration of activated microglia in neurodegenerative diseases is achievable by Positron Emission Tomography (PET) imaging, using dedicated radiopharmaceuticals targeting the translocator protein-18 kDa (TSPO). In this review, we emphasized the major advances made over the last 20 years, thanks to TSPO PET imaging, to define the pathophysiological implication of microglia activation and neuroinflammation in neurodegenerative diseases, including Parkinson's disease, Huntington's disease, dementia, amyotrophic lateral sclerosis, multiple sclerosis, and also in psychiatric disorders. The extent and upregulation of TSPO as a molecular biomarker of activated microglia in the human brain is now widely documented in these pathologies, but its significance, and especially its protective or deleterious action regarding the disease's stage, remains under debate. Thus, we exposed new and plausible suggestions to enhance the contribution of TSPO PET imaging for biomedical research by exploring microglia's role and interactions with other cells in brain parenchyma. Multiplex approaches, associating TSPO PET radiopharmaceuticals with other biomarkers (PET imaging of cellular metabolism, neurotransmission or abnormal protein aggregates, but also other imaging modalities, and peripheral cytokine levels measurement and/or metabolomics analysis) was considered. Finally, the actual clinical impact of TSPO PET imaging as a routine biomarker of neuroinflammation was put into perspective regarding the current development of diagnostic and therapeutic strategies for neurodegenerative diseases.

Keywords: PET; TSPO; microglial activation; neurodegenerative diseases; neuroinflammation; psychiatric disorders; radiopharmaceutical.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. Pelvig D.P., Pakkenberg H., Stark A.K., Pakkenberg B. Neocortical glial cell numbers in human brains. Neurobiol. Aging. 2008;29:1754–1762. doi: 10.1016/j.neurobiolaging.2007.04.013. - DOI - PubMed
    1. Lyck L., Santamaria I.D., Pakkenberg B., Chemnitz J., Schrøder H.D., Finsen B., Gundersen H.J.G. An empirical analysis of the precision of estimating the numbers of neurons and glia in human neocortex using a fractionator-design with sub-sampling. J. Neurosci. Methods. 2009;182:143–156. doi: 10.1016/j.jneumeth.2009.06.003. - DOI - PubMed
    1. Ransohoff R.M., Perry V.H. Microglial physiology: Unique stimuli, specialized responses. Annu. Rev. Immunol. 2009;27:119–145. doi: 10.1146/annurev.immunol.021908.132528. - DOI - PubMed
    1. Reemst K., Noctor S.C., Lucassen P.J., Hol E.M. The Indispensable Roles of Microglia and Astrocytes during Brain Development. Front. Hum. Neurosci. 2016;10:566. - PMC - PubMed
    1. Nimmerjahn A., Kirchhoff F., Helmchen F. Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science. 2005;308:1314–1318. doi: 10.1126/science.1110647. - DOI - PubMed

MeSH terms